Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[ancestry category]	Characteristics[age]	Characteristics[developmental stage]	Characteristics[sex]	Characteristics[disease]	Characteristics[cell type]	Characteristics[biological replicate]	Assay Name	Comment[data file]	Comment[fraction identifier]	Comment [fractionation method]	Comment[technical replicate]	Comment[file uri]	Comment[instrument]	Comment[MS2 analyzer type]	Comment[label]	Comment[cleavage agent details]	Comment[modification parameters]	Comment[modification parameters]	Comment[modification parameters]	Comment[collision energy]	Comment[dissociation method]	Comment[precursor mass tolerance]	Comment[fragment mass tolerance]	Comment[data file]	factor value[Genotype]
PXD012467-Sample-1	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 4	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_A4_170502163320.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_A4_170502163320.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_A4_170502163320.raw	Left Ventricle Donors
PXD012467-Sample-1	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 5	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_A5_170513000650.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_A5_170513000650.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_A5_170513000650.raw	Left Ventricle Donors
PXD012467-Sample-2	Homo sapiens	interventricular septum	not available	47Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 9	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AA4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AA4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AA4.raw	different mutation MYBPC3
PXD012467-Sample-2	Homo sapiens	interventricular septum	not available	47Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run  10	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AA5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AA5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AA5.raw	different mutation MYBPC3
PXD012467-Sample-3	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run  14	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AB4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AB4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AB4.raw	Left Ventricle Donors
PXD012467-Sample-3	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run  15	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AB5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AB5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AB5.raw	Left Ventricle Donors
PXD012467-Sample-4	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run  19	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AC4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AC4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AC4.raw	Left Ventricle Donors
PXD012467-Sample-4	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run  20	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AC5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AC5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AC5.raw	Left Ventricle Donors
PXD012467-Sample-5	Homo sapiens	interventricular septum	not available	58Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run  24	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AD4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AD4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AD4.raw	MYH7 mutation
PXD012467-Sample-5	Homo sapiens	interventricular septum	not available	58Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run  25	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AD5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AD5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AD5.raw	MYH7 mutation
PXD012467-Sample-6	Homo sapiens	interventricular septum	not available	22Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run  29	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AE4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AE4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AE4.raw	different mutation MYBPC3
PXD012467-Sample-6	Homo sapiens	interventricular septum	not available	22Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run  30	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AE5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AE5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AE5.raw	different mutation MYBPC3
PXD012467-Sample-7	Homo sapiens	interventricular septum	not available	22Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run  34	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AF4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AF4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AF4.raw	sarcomere-mutation negative
PXD012467-Sample-7	Homo sapiens	interventricular septum	not available	22Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run  35	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AF5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AF5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AF5.raw	sarcomere-mutation negative
PXD012467-Sample-8	Homo sapiens	interventricular septum	not available	32Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run  39	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AG4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AG4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AG4.raw	2373insG mutated MYBPC3
PXD012467-Sample-8	Homo sapiens	interventricular septum	not available	32Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run  40	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AG5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AG5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AG5.raw	2373insG mutated MYBPC3
PXD012467-Sample-9	Homo sapiens	interventricular septum	not available	46Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run  44	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AH4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AH4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AH4.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-9	Homo sapiens	interventricular septum	not available	46Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run  45	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AH5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AH5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AH5.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-10	Homo sapiens	interventricular septum	not available	48Y	adult	female	healthy	tissue	1	run  49	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AI4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AI4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AI4.raw	Interventricular Septum Donors
PXD012467-Sample-10	Homo sapiens	interventricular septum	not available	48Y	adult	female	healthy	tissue	1	run  50	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AI5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AI5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AI5.raw	Interventricular Septum Donors
PXD012467-Sample-11	Homo sapiens	interventricular septum	not available	55Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 54	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AJ4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AJ4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AJ4.raw	different mutation MYBPC3
PXD012467-Sample-11	Homo sapiens	interventricular septum	not available	55Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 55	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AJ5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AJ5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AJ5.raw	different mutation MYBPC3
PXD012467-Sample-12	Homo sapiens	interventricular septum	not available	53Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 59	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AK4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AK4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AK4.raw	sarcomere-mutation negative
PXD012467-Sample-12	Homo sapiens	interventricular septum	not available	53Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 60	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AK5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AK5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AK5.raw	sarcomere-mutation negative
PXD012467-Sample-13	Homo sapiens	interventricular septum	not available	24Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 64	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AL4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AL4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AL4.raw	different mutation MYBPC3
PXD012467-Sample-13	Homo sapiens	interventricular septum	not available	24Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 65	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AL5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AL5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AL5.raw	different mutation MYBPC3
PXD012467-Sample-14	Homo sapiens	interventricular septum	not available	46Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 69	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AM4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AM4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AM4.raw	MYH7 mutation
PXD012467-Sample-14	Homo sapiens	interventricular septum	not available	46Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 70	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AM5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AM5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AM5.raw	MYH7 mutation
PXD012467-Sample-15	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 74	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AN4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AN4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AN4.raw	Left Ventricle Donors
PXD012467-Sample-15	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 75	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AN5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AN5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AN5.raw	Left Ventricle Donors
PXD012467-Sample-16	Homo sapiens	interventricular septum	not available	57Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 79	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AO4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AO4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AO4.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-16	Homo sapiens	interventricular septum	not available	57Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 80	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AO5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AO5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AO5.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-17	Homo sapiens	interventricular septum	not available	60Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 84	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AP4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AP4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AP4.raw	2373insG mutated MYBPC3
PXD012467-Sample-17	Homo sapiens	interventricular septum	not available	60Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 85	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AP5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AP5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AP5.raw	2373insG mutated MYBPC3
PXD012467-Sample-18	Homo sapiens	interventricular septum	not available	55Y	adult	female	healthy	tissue	1	run 89	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AQ4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AQ4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AQ4.raw	Interventricular Septum Donors
PXD012467-Sample-18	Homo sapiens	interventricular septum	not available	55Y	adult	female	healthy	tissue	1	run 90	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AQ5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AQ5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AQ5.raw	Interventricular Septum Donors
PXD012467-Sample-19	Homo sapiens	interventricular septum	not available	17Y	juvenile stage	male	Hypertrophic cardiomyopathy	tissue	1	run 94	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AR4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AR4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AR4.raw	2373insG mutated MYBPC3
PXD012467-Sample-19	Homo sapiens	interventricular septum	not available	17Y	juvenile stage	male	Hypertrophic cardiomyopathy	tissue	1	run 95	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AR5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AR5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AR5.raw	2373insG mutated MYBPC3
PXD012467-Sample-20	Homo sapiens	interventricular septum	not available	41Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 99	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AS4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AS4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AS4.raw	sarcomere-mutation negative
PXD012467-Sample-20	Homo sapiens	interventricular septum	not available	41Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 100	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AS5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AS5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AS5.raw	sarcomere-mutation negative
PXD012467-Sample-21	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 104	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AT4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AT4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AT4.raw	Left Ventricle Donors
PXD012467-Sample-21	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 105	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AT5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AT5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AT5.raw	Left Ventricle Donors
PXD012467-Sample-22	Homo sapiens	interventricular septum	not available	36Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 109	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AU4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AU4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AU4.raw	different mutation MYBPC3
PXD012467-Sample-22	Homo sapiens	interventricular septum	not available	36Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 110	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AU5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AU5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AU5.raw	different mutation MYBPC3
PXD012467-Sample-23	Homo sapiens	interventricular septum	not available	15Y	juvenile stage	female	Hypertrophic cardiomyopathy	tissue	1	run 114	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AV4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AV4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AV4.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-23	Homo sapiens	interventricular septum	not available	15Y	juvenile stage	female	Hypertrophic cardiomyopathy	tissue	1	run 115	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AV5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AV5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AV5.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-24	Homo sapiens	interventricular septum	not available	34Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 119	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AW4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AW4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AW4.raw	MYH7 mutation
PXD012467-Sample-24	Homo sapiens	interventricular septum	not available	34Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 120	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AW5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AW5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AW5.raw	MYH7 mutation
PXD012467-Sample-25	Homo sapiens	interventricular septum	not available	33Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 124	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AX4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AX4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AX4.raw	different mutation MYBPC3
PXD012467-Sample-25	Homo sapiens	interventricular septum	not available	33Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 125	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AX5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AX5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AX5.raw	different mutation MYBPC3
PXD012467-Sample-26	Homo sapiens	interventricular septum	not available	40Y	adult	male	healthy	tissue	1	run 129	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AY4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AY4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AY4.raw	Interventricular Septum Donors
PXD012467-Sample-26	Homo sapiens	interventricular septum	not available	40Y	adult	male	healthy	tissue	1	run 130	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AY5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AY5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AY5.raw	Interventricular Septum Donors
PXD012467-Sample-27	Homo sapiens	interventricular septum	not available	65Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 134	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AZ4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AZ4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AZ4.raw	sarcomere-mutation negative
PXD012467-Sample-27	Homo sapiens	interventricular septum	not available	65Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 135	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AZ5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AZ5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_AZ5.raw	sarcomere-mutation negative
PXD012467-Sample-28	Homo sapiens	interventricular septum	not available	66Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 139	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_B4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_B4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_B4.raw	MYH7 mutation
PXD012467-Sample-28	Homo sapiens	interventricular septum	not available	66Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 140	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_B5_170513013939.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_B5_170513013939.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_B5_170513013939.raw	MYH7 mutation
PXD012467-Sample-29	Homo sapiens	interventricular septum	not available	26Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 144	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BA4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BA4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BA4.raw	2373insG mutated MYBPC3
PXD012467-Sample-29	Homo sapiens	interventricular septum	not available	26Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 145	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BA5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BA5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BA5.raw	2373insG mutated MYBPC3
PXD012467-Sample-30	Homo sapiens	interventricular septum	not available	68Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 149	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BB4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BB4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BB4.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-30	Homo sapiens	interventricular septum	not available	68Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 150	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BB5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BB5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BB5.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-31	Homo sapiens	interventricular septum	not available	35Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 154	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BC4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BC4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BC4.raw	MYH7 mutation
PXD012467-Sample-31	Homo sapiens	interventricular septum	not available	35Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 155	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BC5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BC5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BC5.raw	MYH7 mutation
PXD012467-Sample-32	Homo sapiens	interventricular septum	not available	62Y	adult	female	healthy	tissue	1	run 159	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BD4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BD4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BD4.raw	Interventricular Septum Donors
PXD012467-Sample-32	Homo sapiens	interventricular septum	not available	62Y	adult	female	healthy	tissue	1	run 160	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BD5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BD5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BD5.raw	Interventricular Septum Donors
PXD012467-Sample-33	Homo sapiens	interventricular septum	not available	49Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 164	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BE4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BE4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BE4.raw	different mutation MYBPC3
PXD012467-Sample-33	Homo sapiens	interventricular septum	not available	49Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 165	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BE5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BE5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BE5.raw	different mutation MYBPC3
PXD012467-Sample-34	Homo sapiens	interventricular septum	not available	71Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 169	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BF4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BF4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BF4.raw	sarcomere-mutation negative
PXD012467-Sample-34	Homo sapiens	interventricular septum	not available	71Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 170	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BF5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BF5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BF5.raw	sarcomere-mutation negative
PXD012467-Sample-35	Homo sapiens	interventricular septum	not available	69Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 174	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BG4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BG4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BG4.raw	MYH7 mutation
PXD012467-Sample-35	Homo sapiens	interventricular septum	not available	69Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 175	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BG5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BG5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BG5.raw	MYH7 mutation
PXD012467-Sample-36	Homo sapiens	interventricular septum	not available	42Y	adult	female	healthy	tissue	1	run 179	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BH4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BH4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BH4.raw	Interventricular Septum Donors
PXD012467-Sample-36	Homo sapiens	interventricular septum	not available	42Y	adult	female	healthy	tissue	1	run 180	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BH5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BH5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BH5.raw	Interventricular Septum Donors
PXD012467-Sample-37	Homo sapiens	interventricular septum	not available	33Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 184	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BI4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BI4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BI4.raw	2373insG mutated MYBPC3
PXD012467-Sample-37	Homo sapiens	interventricular septum	not available	33Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 185	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BI5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BI5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BI5.raw	2373insG mutated MYBPC3
PXD012467-Sample-38	Homo sapiens	interventricular septum	not available	21Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 189	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BJ4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BJ4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BJ4.raw	different mutation MYBPC3
PXD012467-Sample-38	Homo sapiens	interventricular septum	not available	21Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 190	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BJ5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BJ5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BJ5.raw	different mutation MYBPC3
PXD012467-Sample-39	Homo sapiens	interventricular septum	not available	64Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 194	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BK4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BK4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BK4.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-39	Homo sapiens	interventricular septum	not available	64Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 195	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BK5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BK5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BK5.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-40	Homo sapiens	interventricular septum	not available	50Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 199	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BL4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BL4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BL4.raw	sarcomere-mutation negative
PXD012467-Sample-40	Homo sapiens	interventricular septum	not available	50Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 200	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BL5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BL5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BL5.raw	sarcomere-mutation negative
PXD012467-Sample-41	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 204	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BM4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BM4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BM4.raw	Left Ventricle Donors
PXD012467-Sample-41	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 205	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BM5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BM5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_BM5.raw	Left Ventricle Donors
PXD012467-Sample-42	Homo sapiens	interventricular septum	not available	0.2Y	infant	male	Hypertrophic cardiomyopathy	tissue	1	run 209	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_C4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_C4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_C4.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-42	Homo sapiens	interventricular septum	not available	0.2Y	infant	male	Hypertrophic cardiomyopathy	tissue	1	run 210	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_C5_170513031223.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_C5_170513031223.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_C5_170513031223.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-43	Homo sapiens	interventricular septum	not available	53Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 214	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_D4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_D4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_D4.raw	different mutation MYBPC3
PXD012467-Sample-43	Homo sapiens	interventricular septum	not available	53Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 215	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_D5_170513044504.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_D5_170513044504.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_D5_170513044504.raw	different mutation MYBPC3
PXD012467-Sample-44	Homo sapiens	interventricular septum	not available	27Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 219	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_E4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_E4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_E4.raw	2373insG mutated MYBPC3
PXD012467-Sample-44	Homo sapiens	interventricular septum	not available	27Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 220	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_E5_170513061748.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_E5_170513061748.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_E5_170513061748.raw	2373insG mutated MYBPC3
PXD012467-Sample-45	Homo sapiens	interventricular septum	not available	66Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 224	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_F4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_F4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_F4.raw	sarcomere-mutation negative
PXD012467-Sample-45	Homo sapiens	interventricular septum	not available	66Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 225	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_F5_170513075035.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_F5_170513075035.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_F5_170513075035.raw	sarcomere-mutation negative
PXD012467-Sample-46	Homo sapiens	interventricular septum	not available	41Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 229	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_G4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_G4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_G4.raw	MYH7 mutation
PXD012467-Sample-46	Homo sapiens	interventricular septum	not available	41Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 230	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_G5_170513092316.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_G5_170513092316.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_G5_170513092316.raw	MYH7 mutation
PXD012467-Sample-47	Homo sapiens	interventricular septum	not available	59Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 234	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_H4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_H4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_H4.raw	2373insG mutated MYBPC3
PXD012467-Sample-47	Homo sapiens	interventricular septum	not available	59Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 235	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_H5_170513105558.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_H5_170513105558.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_H5_170513105558.raw	2373insG mutated MYBPC3
PXD012467-Sample-48	Homo sapiens	interventricular septum	not available	53Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 239	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_I4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_I4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_I4.raw	different mutation MYBPC3
PXD012467-Sample-48	Homo sapiens	interventricular septum	not available	53Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 240	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_I5_170513122838.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_I5_170513122838.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_I5_170513122838.raw	different mutation MYBPC3
PXD012467-Sample-49	Homo sapiens	interventricular septum	not available	72Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 244	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_J4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_J4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_J4.raw	MYH7 mutation
PXD012467-Sample-49	Homo sapiens	interventricular septum	not available	72Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 245	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_J5_170513140121.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_J5_170513140121.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_J5_170513140121.raw	MYH7 mutation
PXD012467-Sample-50	Homo sapiens	interventricular septum	not available	64Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 249	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_K4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_K4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_K4.raw	sarcomere-mutation negative
PXD012467-Sample-50	Homo sapiens	interventricular septum	not available	64Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 250	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_K5_170509110852.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_K5_170509110852.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_K5_170509110852.raw	sarcomere-mutation negative
PXD012467-Sample-51	Homo sapiens	interventricular septum	not available	69Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 254	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_L4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_L4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_L4.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-51	Homo sapiens	interventricular septum	not available	69Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 255	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_L5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_L5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_L5.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-52	Homo sapiens	interventricular septum	not available	37Y	adult	male	healthy	tissue	1	run 259	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_M4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_M4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_M4.raw	Interventricular Septum Donors
PXD012467-Sample-52	Homo sapiens	interventricular septum	not available	37Y	adult	male	healthy	tissue	1	run 260	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_M5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_M5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_M5.raw	Interventricular Septum Donors
PXD012467-Sample-53	Homo sapiens	interventricular septum	not available	58Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 264	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_N4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_N4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_N4.raw	different mutation MYBPC3
PXD012467-Sample-53	Homo sapiens	interventricular septum	not available	58Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 265	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_N5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_N5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_N5.raw	different mutation MYBPC3
PXD012467-Sample-54	Homo sapiens	interventricular septum	not available	not available	not available	not available	Hypertrophic cardiomyopathy	tissue	1	run 269	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_O4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_O4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_O4.raw	different mutation MYBPC3
PXD012467-Sample-54	Homo sapiens	interventricular septum	not available	not available	not available	not available	Hypertrophic cardiomyopathy	tissue	1	run 270	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_O5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_O5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_O5.raw	different mutation MYBPC3
PXD012467-Sample-55	Homo sapiens	interventricular septum	not available	54Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 274	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_P4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_P4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_P4.raw	sarcomere-mutation negative
PXD012467-Sample-55	Homo sapiens	interventricular septum	not available	54Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 275	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_P5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_P5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_P5.raw	sarcomere-mutation negative
PXD012467-Sample-56	Homo sapiens	interventricular septum	not available	52Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 279	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Q4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Q4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Q4.raw	MYH7 mutation
PXD012467-Sample-56	Homo sapiens	interventricular septum	not available	52Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 280	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Q5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Q5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Q5.raw	MYH7 mutation
PXD012467-Sample-57	Homo sapiens	interventricular septum	not available	40Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 284	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_R4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_R4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_R4.raw	2373insG mutated MYBPC3
PXD012467-Sample-57	Homo sapiens	interventricular septum	not available	40Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 285	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_R5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_R5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_R5.raw	2373insG mutated MYBPC3
PXD012467-Sample-58	Homo sapiens	interventricular septum	not available	58Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 289	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_S4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_S4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_S4.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-58	Homo sapiens	interventricular septum	not available	58Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 290	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_S5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_S5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_S5.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-59	Homo sapiens	interventricular septum	not available	46Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 294	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_T4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_T4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_T4.raw	sarcomere-mutation negative
PXD012467-Sample-59	Homo sapiens	interventricular septum	not available	46Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 295	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_T5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_T5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_T5.raw	sarcomere-mutation negative
PXD012467-Sample-60	Homo sapiens	interventricular septum	not available	33Y	adult	male	healthy	tissue	1	run 299	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_U4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_U4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_U4.raw	Interventricular Septum Donors
PXD012467-Sample-60	Homo sapiens	interventricular septum	not available	33Y	adult	male	healthy	tissue	1	run 300	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_U5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_U5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_U5.raw	Interventricular Septum Donors
PXD012467-Sample-61	Homo sapiens	interventricular septum	not available	61Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 304	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_V4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_V4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_V4.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-61	Homo sapiens	interventricular septum	not available	61Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 305	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_V5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_V5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_V5.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-62	Homo sapiens	interventricular septum	not available	50Y	adult	female	healthy	tissue	1	run 309	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_W4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_W4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_W4.raw	Interventricular Septum Donors
PXD012467-Sample-62	Homo sapiens	interventricular septum	not available	50Y	adult	female	healthy	tissue	1	run 310	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_W5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_W5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_W5.raw	Interventricular Septum Donors
PXD012467-Sample-63	Homo sapiens	interventricular septum	not available	52Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 314	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_X4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_X4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_X4.raw	2373insG mutated MYBPC3
PXD012467-Sample-63	Homo sapiens	interventricular septum	not available	52Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 315	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_X5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_X5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_X5.raw	2373insG mutated MYBPC3
PXD012467-Sample-64	Homo sapiens	interventricular septum	not available	66Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 319	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Y4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Y4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Y4.raw	MYH7 mutation
PXD012467-Sample-64	Homo sapiens	interventricular septum	not available	66Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 320	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Y5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Y5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Y5.raw	MYH7 mutation
PXD012467-Sample-65	Homo sapiens	interventricular septum	not available	57Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 324	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Z4.raw	4	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Z4.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Z4.raw	sarcomere-mutation negative
PXD012467-Sample-65	Homo sapiens	interventricular septum	not available	57Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 325	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Z5.raw	5	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Z5.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE1_170502_OPL3018_MS_DK_CVON_DOSIS_Z5.raw	sarcomere-mutation negative
PXD012467-Sample-1	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 1	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_A1_170421200346.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_A1_170421200346.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_A1_170421200346.raw	Left Ventricle Donors
PXD012467-Sample-1	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 2	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_A2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_A2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_A2.raw	Left Ventricle Donors
PXD012467-Sample-1	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 3	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_A3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_A3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_A3.raw	Left Ventricle Donors
PXD012467-Sample-2	Homo sapiens	interventricular septum	not available	47Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 6	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AA1_170423121204.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AA1_170423121204.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AA1_170423121204.raw	different mutation MYBPC3
PXD012467-Sample-2	Homo sapiens	interventricular septum	not available	47Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 7	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AA2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AA2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AA2.raw	different mutation MYBPC3
PXD012467-Sample-2	Homo sapiens	interventricular septum	not available	47Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 8	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AA3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AA3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AA3.raw	different mutation MYBPC3
PXD012467-Sample-3	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 11	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AB1_170423134440.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AB1_170423134440.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AB1_170423134440.raw	Left Ventricle Donors
PXD012467-Sample-3	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 12	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AB2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AB2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AB2.raw	Left Ventricle Donors
PXD012467-Sample-3	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 13	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AB3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AB3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AB3.raw	Left Ventricle Donors
PXD012467-Sample-4	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 16	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AC1_170419105457.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AC1_170419105457.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AC1_170419105457.raw	Left Ventricle Donors
PXD012467-Sample-4	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 17	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AC2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AC2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AC2.raw	Left Ventricle Donors
PXD012467-Sample-4	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 18	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AC3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AC3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AC3.raw	Left Ventricle Donors
PXD012467-Sample-5	Homo sapiens	interventricular septum	not available	58Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 21	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AD1_170419122747.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AD1_170419122747.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AD1_170419122747.raw	MYH7 mutation
PXD012467-Sample-5	Homo sapiens	interventricular septum	not available	58Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 22	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AD2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AD2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AD2.raw	MYH7 mutation
PXD012467-Sample-5	Homo sapiens	interventricular septum	not available	58Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 23	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AD3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AD3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AD3.raw	MYH7 mutation
PXD012467-Sample-6	Homo sapiens	interventricular septum	not available	22Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 26	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AE1_170419140024.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AE1_170419140024.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AE1_170419140024.raw	different mutation MYBPC3
PXD012467-Sample-6	Homo sapiens	interventricular septum	not available	22Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 27	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AE2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AE2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AE2.raw	different mutation MYBPC3
PXD012467-Sample-6	Homo sapiens	interventricular septum	not available	22Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 28	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AE3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AE3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AE3.raw	different mutation MYBPC3
PXD012467-Sample-7	Homo sapiens	interventricular septum	not available	22Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 31	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AF1_170419153307.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AF1_170419153307.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AF1_170419153307.raw	sarcomere-mutation negative
PXD012467-Sample-7	Homo sapiens	interventricular septum	not available	22Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 32	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AF2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AF2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AF2.raw	sarcomere-mutation negative
PXD012467-Sample-7	Homo sapiens	interventricular septum	not available	22Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 33	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AF3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AF3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AF3.raw	sarcomere-mutation negative
PXD012467-Sample-8	Homo sapiens	interventricular septum	not available	32Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 36	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AG1_170419170544.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AG1_170419170544.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AG1_170419170544.raw	2373insG mutated MYBPC3
PXD012467-Sample-8	Homo sapiens	interventricular septum	not available	32Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 37	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AG2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AG2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AG2.raw	2373insG mutated MYBPC3
PXD012467-Sample-8	Homo sapiens	interventricular septum	not available	32Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 38	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AG3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AG3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AG3.raw	2373insG mutated MYBPC3
PXD012467-Sample-9	Homo sapiens	interventricular septum	not available	46Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 41	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AH1_170419183823.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AH1_170419183823.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AH1_170419183823.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-9	Homo sapiens	interventricular septum	not available	46Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 42	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AH2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AH2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AH2.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-9	Homo sapiens	interventricular septum	not available	46Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 43	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AH3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AH3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AH3.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-10	Homo sapiens	interventricular septum	not available	48Y	adult	female	healthy	tissue	1	run 46	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AI1_170419201106.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AI1_170419201106.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AI1_170419201106.raw	Interventricular Septum Donors
PXD012467-Sample-10	Homo sapiens	interventricular septum	not available	48Y	adult	female	healthy	tissue	1	run 47	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AI2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AI2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AI2.raw	Interventricular Septum Donors
PXD012467-Sample-10	Homo sapiens	interventricular septum	not available	48Y	adult	female	healthy	tissue	1	run 48	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AI3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AI3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AI3.raw	Interventricular Septum Donors
PXD012467-Sample-11	Homo sapiens	interventricular septum	not available	55Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 51	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AJ1_170419214345.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AJ1_170419214345.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AJ1_170419214345.raw	different mutation MYBPC3
PXD012467-Sample-11	Homo sapiens	interventricular septum	not available	55Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 52	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AJ2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AJ2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AJ2.raw	different mutation MYBPC3
PXD012467-Sample-11	Homo sapiens	interventricular septum	not available	55Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 53	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AJ3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AJ3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AJ3.raw	different mutation MYBPC3
PXD012467-Sample-12	Homo sapiens	interventricular septum	not available	53Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 56	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AK1_170419231626.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AK1_170419231626.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AK1_170419231626.raw	sarcomere-mutation negative
PXD012467-Sample-12	Homo sapiens	interventricular septum	not available	53Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 57	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AK2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AK2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AK2.raw	sarcomere-mutation negative
PXD012467-Sample-12	Homo sapiens	interventricular septum	not available	53Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 58	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AK3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AK3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AK3.raw	sarcomere-mutation negative
PXD012467-Sample-13	Homo sapiens	interventricular septum	not available	24Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 61	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AL1_170420004902.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AL1_170420004902.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AL1_170420004902.raw	different mutation MYBPC3
PXD012467-Sample-13	Homo sapiens	interventricular septum	not available	24Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 62	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AL2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AL2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AL2.raw	different mutation MYBPC3
PXD012467-Sample-13	Homo sapiens	interventricular septum	not available	24Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 63	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AL3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AL3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AL3.raw	different mutation MYBPC3
PXD012467-Sample-14	Homo sapiens	interventricular septum	not available	46Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 66	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AM1_170420022142.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AM1_170420022142.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AM1_170420022142.raw	MYH7 mutation
PXD012467-Sample-14	Homo sapiens	interventricular septum	not available	46Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 67	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AM2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AM2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AM2.raw	MYH7 mutation
PXD012467-Sample-14	Homo sapiens	interventricular septum	not available	46Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 68	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AM3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AM3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AM3.raw	MYH7 mutation
PXD012467-Sample-15	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 71	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AN1_170420035421.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AN1_170420035421.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AN1_170420035421.raw	Left Ventricle Donors
PXD012467-Sample-15	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 72	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AN2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AN2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AN2.raw	Left Ventricle Donors
PXD012467-Sample-15	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 73	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AN3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AN3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AN3.raw	Left Ventricle Donors
PXD012467-Sample-16	Homo sapiens	interventricular septum	not available	57Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 76	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AO1_170420052710.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AO1_170420052710.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AO1_170420052710.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-16	Homo sapiens	interventricular septum	not available	57Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 77	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AO2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AO2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AO2.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-16	Homo sapiens	interventricular septum	not available	57Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 78	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AO3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AO3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AO3.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-17	Homo sapiens	interventricular septum	not available	60Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 81	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AP1_170420065955.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AP1_170420065955.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AP1_170420065955.raw	2373insG mutated MYBPC3
PXD012467-Sample-17	Homo sapiens	interventricular septum	not available	60Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 82	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AP2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AP2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AP2.raw	2373insG mutated MYBPC3
PXD012467-Sample-17	Homo sapiens	interventricular septum	not available	60Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 83	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AP3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AP3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AP3.raw	2373insG mutated MYBPC3
PXD012467-Sample-18	Homo sapiens	interventricular septum	not available	55Y	adult	female	healthy	tissue	1	run 86	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AQ1_170420083238.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AQ1_170420083238.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AQ1_170420083238.raw	Interventricular Septum Donors
PXD012467-Sample-18	Homo sapiens	interventricular septum	not available	55Y	adult	female	healthy	tissue	1	run 87	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AQ2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AQ2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AQ2.raw	Interventricular Septum Donors
PXD012467-Sample-18	Homo sapiens	interventricular septum	not available	55Y	adult	female	healthy	tissue	1	run 88	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AQ3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AQ3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AQ3.raw	Interventricular Septum Donors
PXD012467-Sample-19	Homo sapiens	interventricular septum	not available	17Y	juvenile stage	male	Hypertrophic cardiomyopathy	tissue	1	run 91	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AR1_170420100518.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AR1_170420100518.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AR1_170420100518.raw	2373insG mutated MYBPC3
PXD012467-Sample-19	Homo sapiens	interventricular septum	not available	17Y	juvenile stage	male	Hypertrophic cardiomyopathy	tissue	1	run 92	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AR2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AR2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AR2.raw	2373insG mutated MYBPC3
PXD012467-Sample-19	Homo sapiens	interventricular septum	not available	17Y	juvenile stage	male	Hypertrophic cardiomyopathy	tissue	1	run 93	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AR3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AR3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AR3.raw	2373insG mutated MYBPC3
PXD012467-Sample-20	Homo sapiens	interventricular septum	not available	41Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 96	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AS1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AS1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AS1.raw	sarcomere-mutation negative
PXD012467-Sample-20	Homo sapiens	interventricular septum	not available	41Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 97	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AS2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AS2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AS2.raw	sarcomere-mutation negative
PXD012467-Sample-20	Homo sapiens	interventricular septum	not available	41Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 98	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AS3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AS3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AS3.raw	sarcomere-mutation negative
PXD012467-Sample-21	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 101	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AT1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AT1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AT1.raw	Left Ventricle Donors
PXD012467-Sample-21	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 102	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AT2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AT2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AT2.raw	Left Ventricle Donors
PXD012467-Sample-21	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 103	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AT3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AT3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AT3.raw	Left Ventricle Donors
PXD012467-Sample-22	Homo sapiens	interventricular septum	not available	36Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 106	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AU1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AU1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AU1.raw	different mutation MYBPC3
PXD012467-Sample-22	Homo sapiens	interventricular septum	not available	36Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 107	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AU2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AU2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AU2.raw	different mutation MYBPC3
PXD012467-Sample-22	Homo sapiens	interventricular septum	not available	36Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 108	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AU3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AU3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AU3.raw	different mutation MYBPC3
PXD012467-Sample-23	Homo sapiens	interventricular septum	not available	15Y	juvenile stage	female	Hypertrophic cardiomyopathy	tissue	1	run 111	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AV1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AV1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AV1.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-23	Homo sapiens	interventricular septum	not available	15Y	juvenile stage	female	Hypertrophic cardiomyopathy	tissue	1	run 112	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AV2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AV2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AV2.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-23	Homo sapiens	interventricular septum	not available	15Y	juvenile stage	female	Hypertrophic cardiomyopathy	tissue	1	run 113	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AV3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AV3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AV3.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-24	Homo sapiens	interventricular septum	not available	34Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 116	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AW1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AW1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AW1.raw	MYH7 mutation
PXD012467-Sample-24	Homo sapiens	interventricular septum	not available	34Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 117	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AW2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AW2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AW2.raw	MYH7 mutation
PXD012467-Sample-24	Homo sapiens	interventricular septum	not available	34Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 118	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AW3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AW3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AW3.raw	MYH7 mutation
PXD012467-Sample-25	Homo sapiens	interventricular septum	not available	33Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 121	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AX1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AX1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AX1.raw	different mutation MYBPC3
PXD012467-Sample-25	Homo sapiens	interventricular septum	not available	33Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 122	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AX2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AX2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AX2.raw	different mutation MYBPC3
PXD012467-Sample-25	Homo sapiens	interventricular septum	not available	33Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 123	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AX3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AX3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AX3.raw	different mutation MYBPC3
PXD012467-Sample-26	Homo sapiens	interventricular septum	not available	40Y	adult	male	healthy	tissue	1	run 126	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AY1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AY1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AY1.raw	Interventricular Septum Donors
PXD012467-Sample-26	Homo sapiens	interventricular septum	not available	40Y	adult	male	healthy	tissue	1	run 127	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AY2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AY2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AY2.raw	Interventricular Septum Donors
PXD012467-Sample-26	Homo sapiens	interventricular septum	not available	40Y	adult	male	healthy	tissue	1	run 128	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AY3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AY3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AY3.raw	Interventricular Septum Donors
PXD012467-Sample-27	Homo sapiens	interventricular septum	not available	65Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 131	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AZ1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AZ1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AZ1.raw	sarcomere-mutation negative
PXD012467-Sample-27	Homo sapiens	interventricular septum	not available	65Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 132	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AZ2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AZ2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AZ2.raw	sarcomere-mutation negative
PXD012467-Sample-27	Homo sapiens	interventricular septum	not available	65Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 133	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AZ3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AZ3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_AZ3.raw	sarcomere-mutation negative
PXD012467-Sample-28	Homo sapiens	interventricular septum	not available	66Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 136	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_B1_170421213636.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_B1_170421213636.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_B1_170421213636.raw	MYH7 mutation
PXD012467-Sample-28	Homo sapiens	interventricular septum	not available	66Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 137	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_B2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_B2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_B2.raw	MYH7 mutation
PXD012467-Sample-28	Homo sapiens	interventricular septum	not available	66Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 138	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_B3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_B3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_B3.raw	MYH7 mutation
PXD012467-Sample-29	Homo sapiens	interventricular septum	not available	26Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 141	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BA1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BA1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BA1.raw	2373insG mutated MYBPC3
PXD012467-Sample-29	Homo sapiens	interventricular septum	not available	26Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 142	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BA2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BA2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BA2.raw	2373insG mutated MYBPC3
PXD012467-Sample-29	Homo sapiens	interventricular septum	not available	26Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 143	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BA3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BA3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BA3.raw	2373insG mutated MYBPC3
PXD012467-Sample-30	Homo sapiens	interventricular septum	not available	68Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 146	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BB1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BB1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BB1.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-30	Homo sapiens	interventricular septum	not available	68Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 147	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BB2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BB2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BB2.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-30	Homo sapiens	interventricular septum	not available	68Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 148	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BB3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BB3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BB3.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-31	Homo sapiens	interventricular septum	not available	35Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 151	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BC1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BC1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BC1.raw	MYH7 mutation
PXD012467-Sample-31	Homo sapiens	interventricular septum	not available	35Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 152	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BC2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BC2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BC2.raw	MYH7 mutation
PXD012467-Sample-31	Homo sapiens	interventricular septum	not available	35Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 153	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BC3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BC3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BC3.raw	MYH7 mutation
PXD012467-Sample-32	Homo sapiens	interventricular septum	not available	62Y	adult	female	healthy	tissue	1	run 156	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BD1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BD1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BD1.raw	Interventricular Septum Donors
PXD012467-Sample-32	Homo sapiens	interventricular septum	not available	62Y	adult	female	healthy	tissue	1	run 157	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BD2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BD2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BD2.raw	Interventricular Septum Donors
PXD012467-Sample-32	Homo sapiens	interventricular septum	not available	62Y	adult	female	healthy	tissue	1	run 158	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BD3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BD3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BD3.raw	Interventricular Septum Donors
PXD012467-Sample-33	Homo sapiens	interventricular septum	not available	49Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 161	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BE1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BE1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BE1.raw	different mutation MYBPC3
PXD012467-Sample-33	Homo sapiens	interventricular septum	not available	49Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 162	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BE2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BE2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BE2.raw	different mutation MYBPC3
PXD012467-Sample-33	Homo sapiens	interventricular septum	not available	49Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 163	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BE3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BE3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BE3.raw	different mutation MYBPC3
PXD012467-Sample-34	Homo sapiens	interventricular septum	not available	71Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 166	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BF1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BF1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BF1.raw	sarcomere-mutation negative
PXD012467-Sample-34	Homo sapiens	interventricular septum	not available	71Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 167	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BF2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BF2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BF2.raw	sarcomere-mutation negative
PXD012467-Sample-34	Homo sapiens	interventricular septum	not available	71Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 168	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BF3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BF3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BF3.raw	sarcomere-mutation negative
PXD012467-Sample-35	Homo sapiens	interventricular septum	not available	69Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 171	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BG1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BG1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BG1.raw	MYH7 mutation
PXD012467-Sample-35	Homo sapiens	interventricular septum	not available	69Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 172	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BG2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BG2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BG2.raw	MYH7 mutation
PXD012467-Sample-35	Homo sapiens	interventricular septum	not available	69Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 173	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BG3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BG3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BG3.raw	MYH7 mutation
PXD012467-Sample-36	Homo sapiens	interventricular septum	not available	42Y	adult	female	healthy	tissue	1	run 176	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BH1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BH1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BH1.raw	Interventricular Septum Donors
PXD012467-Sample-36	Homo sapiens	interventricular septum	not available	42Y	adult	female	healthy	tissue	1	run 177	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BH2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BH2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BH2.raw	Interventricular Septum Donors
PXD012467-Sample-36	Homo sapiens	interventricular septum	not available	42Y	adult	female	healthy	tissue	1	run 178	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BH3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BH3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BH3.raw	Interventricular Septum Donors
PXD012467-Sample-37	Homo sapiens	interventricular septum	not available	33Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 181	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BI1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BI1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BI1.raw	2373insG mutated MYBPC3
PXD012467-Sample-37	Homo sapiens	interventricular septum	not available	33Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 182	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BI2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BI2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BI2.raw	2373insG mutated MYBPC3
PXD012467-Sample-37	Homo sapiens	interventricular septum	not available	33Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 183	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BI3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BI3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BI3.raw	2373insG mutated MYBPC3
PXD012467-Sample-38	Homo sapiens	interventricular septum	not available	21Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 186	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BJ1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BJ1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BJ1.raw	different mutation MYBPC3
PXD012467-Sample-38	Homo sapiens	interventricular septum	not available	21Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 187	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BJ2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BJ2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BJ2.raw	different mutation MYBPC3
PXD012467-Sample-38	Homo sapiens	interventricular septum	not available	21Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 188	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BJ3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BJ3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BJ3.raw	different mutation MYBPC3
PXD012467-Sample-39	Homo sapiens	interventricular septum	not available	64Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 191	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BK1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BK1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BK1.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-39	Homo sapiens	interventricular septum	not available	64Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 192	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BK2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BK2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BK2.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-39	Homo sapiens	interventricular septum	not available	64Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 193	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BK3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BK3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BK3.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-40	Homo sapiens	interventricular septum	not available	50Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 196	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BL1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BL1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BL1.raw	sarcomere-mutation negative
PXD012467-Sample-40	Homo sapiens	interventricular septum	not available	50Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 197	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BL2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BL2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BL2.raw	sarcomere-mutation negative
PXD012467-Sample-40	Homo sapiens	interventricular septum	not available	50Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 198	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BL3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BL3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BL3.raw	sarcomere-mutation negative
PXD012467-Sample-41	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 201	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BM1.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BM1.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BM1.raw	Left Ventricle Donors
PXD012467-Sample-41	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 202	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BM2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BM2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BM2.raw	Left Ventricle Donors
PXD012467-Sample-41	Homo sapiens	left ventricular	not available	not available	not available	not available	not available	not available	1	run 203	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BM3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BM3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_BM3.raw	Left Ventricle Donors
PXD012467-Sample-42	Homo sapiens	interventricular septum	not available	0.2Y	infant	male	Hypertrophic cardiomyopathy	tissue	1	run 206	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_C1_170421230915.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_C1_170421230915.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_C1_170421230915.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-42	Homo sapiens	interventricular septum	not available	0.2Y	infant	male	Hypertrophic cardiomyopathy	tissue	1	run 207	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_C2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_C2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_C2.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-42	Homo sapiens	interventricular septum	not available	0.2Y	infant	male	Hypertrophic cardiomyopathy	tissue	1	run 208	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_C3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_C3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_C3.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-43	Homo sapiens	interventricular septum	not available	53Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 211	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_D1_170422004151.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_D1_170422004151.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_D1_170422004151.raw	different mutation MYBPC3
PXD012467-Sample-43	Homo sapiens	interventricular septum	not available	53Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 212	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_D2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_D2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_D2.raw	different mutation MYBPC3
PXD012467-Sample-43	Homo sapiens	interventricular septum	not available	53Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 213	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_D3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_D3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_D3.raw	different mutation MYBPC3
PXD012467-Sample-44	Homo sapiens	interventricular septum	not available	27Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 216	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_E1_170422021429.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_E1_170422021429.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_E1_170422021429.raw	2373insG mutated MYBPC3
PXD012467-Sample-44	Homo sapiens	interventricular septum	not available	27Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 217	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_E2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_E2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_E2.raw	2373insG mutated MYBPC3
PXD012467-Sample-44	Homo sapiens	interventricular septum	not available	27Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 218	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_E3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_E3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_E3.raw	2373insG mutated MYBPC3
PXD012467-Sample-45	Homo sapiens	interventricular septum	not available	66Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 221	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_F1_170422034708.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_F1_170422034708.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_F1_170422034708.raw	sarcomere-mutation negative
PXD012467-Sample-45	Homo sapiens	interventricular septum	not available	66Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 222	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_F2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_F2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_F2.raw	sarcomere-mutation negative
PXD012467-Sample-45	Homo sapiens	interventricular septum	not available	66Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 223	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_F3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_F3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_F3.raw	sarcomere-mutation negative
PXD012467-Sample-46	Homo sapiens	interventricular septum	not available	41Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 226	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_G1_170422051946.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_G1_170422051946.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_G1_170422051946.raw	MYH7 mutation
PXD012467-Sample-46	Homo sapiens	interventricular septum	not available	41Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 227	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_G2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_G2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_G2.raw	MYH7 mutation
PXD012467-Sample-46	Homo sapiens	interventricular septum	not available	41Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 228	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_G3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_G3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_G3.raw	MYH7 mutation
PXD012467-Sample-47	Homo sapiens	interventricular septum	not available	59Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 231	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_H1_170422065222.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_H1_170422065222.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_H1_170422065222.raw	2373insG mutated MYBPC3
PXD012467-Sample-47	Homo sapiens	interventricular septum	not available	59Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 232	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_H2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_H2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_H2.raw	2373insG mutated MYBPC3
PXD012467-Sample-47	Homo sapiens	interventricular septum	not available	59Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 233	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_H3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_H3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_H3.raw	2373insG mutated MYBPC3
PXD012467-Sample-48	Homo sapiens	interventricular septum	not available	53Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 236	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_I1_170422082458.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_I1_170422082458.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_I1_170422082458.raw	different mutation MYBPC3
PXD012467-Sample-48	Homo sapiens	interventricular septum	not available	53Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 237	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_I2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_I2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_I2.raw	different mutation MYBPC3
PXD012467-Sample-48	Homo sapiens	interventricular septum	not available	53Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 238	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_I3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_I3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_I3.raw	different mutation MYBPC3
PXD012467-Sample-49	Homo sapiens	interventricular septum	not available	72Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 241	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_J1_170422095735.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_J1_170422095735.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_J1_170422095735.raw	MYH7 mutation
PXD012467-Sample-49	Homo sapiens	interventricular septum	not available	72Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 242	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_J2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_J2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_J2.raw	MYH7 mutation
PXD012467-Sample-49	Homo sapiens	interventricular septum	not available	72Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 243	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_J3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_J3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_J3.raw	MYH7 mutation
PXD012467-Sample-50	Homo sapiens	interventricular septum	not available	64Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 246	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_K1_170422113012.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_K1_170422113012.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_K1_170422113012.raw	sarcomere-mutation negative
PXD012467-Sample-50	Homo sapiens	interventricular septum	not available	64Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 247	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_K2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_K2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_K2.raw	sarcomere-mutation negative
PXD012467-Sample-50	Homo sapiens	interventricular septum	not available	64Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 248	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_K3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_K3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_K3.raw	sarcomere-mutation negative
PXD012467-Sample-51	Homo sapiens	interventricular septum	not available	69Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 251	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_L1_170422130247.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_L1_170422130247.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_L1_170422130247.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-51	Homo sapiens	interventricular septum	not available	69Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 252	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_L2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_L2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_L2.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-51	Homo sapiens	interventricular septum	not available	69Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 253	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_L3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_L3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_L3.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-52	Homo sapiens	interventricular septum	not available	37Y	adult	male	healthy	tissue	1	run 256	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_M1_170422143524.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_M1_170422143524.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_M1_170422143524.raw	Interventricular Septum Donors
PXD012467-Sample-52	Homo sapiens	interventricular septum	not available	37Y	adult	male	healthy	tissue	1	run 257	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_M2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_M2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_M2.raw	Interventricular Septum Donors
PXD012467-Sample-52	Homo sapiens	interventricular septum	not available	37Y	adult	male	healthy	tissue	1	run 258	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_M3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_M3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_M3.raw	Interventricular Septum Donors
PXD012467-Sample-53	Homo sapiens	interventricular septum	not available	58Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 261	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_N1_170422160800.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_N1_170422160800.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_N1_170422160800.raw	different mutation MYBPC3
PXD012467-Sample-53	Homo sapiens	interventricular septum	not available	58Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 262	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_N2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_N2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_N2.raw	different mutation MYBPC3
PXD012467-Sample-53	Homo sapiens	interventricular septum	not available	58Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 263	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_N3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_N3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_N3.raw	different mutation MYBPC3
PXD012467-Sample-54	Homo sapiens	interventricular septum	not available	not available	not available	not available	Hypertrophic cardiomyopathy	tissue	1	run 266	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_O1_170422174036.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_O1_170422174036.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_O1_170422174036.raw	different mutation MYBPC3
PXD012467-Sample-54	Homo sapiens	interventricular septum	not available	not available	not available	not available	Hypertrophic cardiomyopathy	tissue	1	run 267	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_O2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_O2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_O2.raw	different mutation MYBPC3
PXD012467-Sample-54	Homo sapiens	interventricular septum	not available	not available	not available	not available	Hypertrophic cardiomyopathy	tissue	1	run 268	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_O3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_O3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_O3.raw	different mutation MYBPC3
PXD012467-Sample-55	Homo sapiens	interventricular septum	not available	54Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 271	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_P1_170422191313.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_P1_170422191313.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_P1_170422191313.raw	sarcomere-mutation negative
PXD012467-Sample-55	Homo sapiens	interventricular septum	not available	54Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 272	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_P2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_P2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_P2.raw	sarcomere-mutation negative
PXD012467-Sample-55	Homo sapiens	interventricular septum	not available	54Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 273	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_P3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_P3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_P3.raw	sarcomere-mutation negative
PXD012467-Sample-56	Homo sapiens	interventricular septum	not available	52Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 276	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Q1_170422204550.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Q1_170422204550.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Q1_170422204550.raw	MYH7 mutation
PXD012467-Sample-56	Homo sapiens	interventricular septum	not available	52Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 277	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Q2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Q2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Q2.raw	MYH7 mutation
PXD012467-Sample-56	Homo sapiens	interventricular septum	not available	52Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 278	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Q3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Q3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Q3.raw	MYH7 mutation
PXD012467-Sample-57	Homo sapiens	interventricular septum	not available	40Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 281	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_R1_170422221828.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_R1_170422221828.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_R1_170422221828.raw	2373insG mutated MYBPC3
PXD012467-Sample-57	Homo sapiens	interventricular septum	not available	40Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 282	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_R2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_R2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_R2.raw	2373insG mutated MYBPC3
PXD012467-Sample-57	Homo sapiens	interventricular septum	not available	40Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 283	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_R3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_R3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_R3.raw	2373insG mutated MYBPC3
PXD012467-Sample-58	Homo sapiens	interventricular septum	not available	58Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 286	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_S1_170422235108.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_S1_170422235108.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_S1_170422235108.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-58	Homo sapiens	interventricular septum	not available	58Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 287	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_S2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_S2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_S2.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-58	Homo sapiens	interventricular septum	not available	58Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 288	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_S3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_S3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_S3.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-59	Homo sapiens	interventricular septum	not available	46Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 291	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_T1_170423012346.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_T1_170423012346.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_T1_170423012346.raw	sarcomere-mutation negative
PXD012467-Sample-59	Homo sapiens	interventricular septum	not available	46Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 292	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_T2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_T2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_T2.raw	sarcomere-mutation negative
PXD012467-Sample-59	Homo sapiens	interventricular septum	not available	46Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 293	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_T3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_T3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_T3.raw	sarcomere-mutation negative
PXD012467-Sample-60	Homo sapiens	interventricular septum	not available	33Y	adult	male	healthy	tissue	1	run 296	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_U1_170423025622.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_U1_170423025622.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_U1_170423025622.raw	Interventricular Septum Donors
PXD012467-Sample-60	Homo sapiens	interventricular septum	not available	33Y	adult	male	healthy	tissue	1	run 297	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_U2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_U2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_U2.raw	Interventricular Septum Donors
PXD012467-Sample-60	Homo sapiens	interventricular septum	not available	33Y	adult	male	healthy	tissue	1	run 298	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_U3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_U3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_U3.raw	Interventricular Septum Donors
PXD012467-Sample-61	Homo sapiens	interventricular septum	not available	61Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 311	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_V1_170423042858.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_V1_170423042858.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_V1_170423042858.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-61	Homo sapiens	interventricular septum	not available	61Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 312	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_V2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_V2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_V2.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-61	Homo sapiens	interventricular septum	not available	61Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 313	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_V3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_V3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_V3.raw	TNNI3/TNNT2/TPM/MLC2 mut
PXD012467-Sample-62	Homo sapiens	interventricular septum	not available	50Y	adult	female	healthy	tissue	1	run 316	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_W1_170423060134.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_W1_170423060134.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_W1_170423060134.raw	Interventricular Septum Donors
PXD012467-Sample-62	Homo sapiens	interventricular septum	not available	50Y	adult	female	healthy	tissue	1	run 317	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_W2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_W2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_W2.raw	Interventricular Septum Donors
PXD012467-Sample-62	Homo sapiens	interventricular septum	not available	50Y	adult	female	healthy	tissue	1	run 318	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_W3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_W3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_W3.raw	Interventricular Septum Donors
PXD012467-Sample-63	Homo sapiens	interventricular septum	not available	52Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 321	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_X1_170423073414.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_X1_170423073414.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_X1_170423073414.raw	2373insG mutated MYBPC3
PXD012467-Sample-63	Homo sapiens	interventricular septum	not available	52Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 322	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_X2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_X2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_X2.raw	2373insG mutated MYBPC3
PXD012467-Sample-63	Homo sapiens	interventricular septum	not available	52Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 323	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_X3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_X3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_X3.raw	2373insG mutated MYBPC3
PXD012467-Sample-64	Homo sapiens	interventricular septum	not available	66Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 326	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Y1_170423090651.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Y1_170423090651.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Y1_170423090651.raw	MYH7 mutation
PXD012467-Sample-64	Homo sapiens	interventricular septum	not available	66Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 327	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Y2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Y2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Y2.raw	MYH7 mutation
PXD012467-Sample-64	Homo sapiens	interventricular septum	not available	66Y	adult	female	Hypertrophic cardiomyopathy	tissue	1	run 328	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Y3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Y3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Y3.raw	MYH7 mutation
PXD012467-Sample-65	Homo sapiens	interventricular septum	not available	57Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 331	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Z1_170423103927.raw	1	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Z1_170423103927.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Z1_170423103927.raw	sarcomere-mutation negative
PXD012467-Sample-65	Homo sapiens	interventricular septum	not available	57Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 332	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Z2.raw	2	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Z2.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Z2.raw	sarcomere-mutation negative
PXD012467-Sample-65	Homo sapiens	interventricular septum	not available	57Y	adult	male	Hypertrophic cardiomyopathy	tissue	1	run 333	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Z3.raw	3	1D SDS PAGE	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/01/PXD012467/QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Z3.raw	NT=Q Exactive;AC=MS:1001911	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=Protein N-term;AC=UNIMOD:1;MT=Variable	25% NCE	HCD	4.5 ppm	20 ppm	QE2_170403_OPL3018_MS_DK_CVON_DOSIS_Z3.raw	sarcomere-mutation negative
